Third Arc Bio vs Palo Alto Networks

Side-by-side comparison of AI visibility scores, market position, and capabilities

Palo Alto Networks leads in AI visibility (84 vs 25)
Third Arc Bio logo

Third Arc Bio

EmergingBioTech

Multifunctional Antibodies (T Cell Engagers)

Raised $52M Series A extension (Feb 2026) from a16z as new investor — total $217M. ARC101 (bispecific T cell engager, CLDN6+) in Phase 1 solid tumors. Platform spans oncology and autoimmune.

AI VisibilityBeta
Overall Score
D25
Category Rank
#1 of 1
AI Consensus
55%
Trend
up
Per Platform
ChatGPT
31
Perplexity
33
Gemini
35

About

Third Arc Bio raised a $52 million Series A extension in February 2026 with Andreessen Horowitz as a new investor, building on its prior $165 million Series A to reach $217 million in total financing. The company develops multifunctional antibodies — protein therapeutics that combine multiple mechanisms of action in a single molecule — with its lead program ARC101 being a bispecific T cell engager targeting CLDN6 in solid tumors, currently in Phase 1 clinical trials.

Full profile
Palo Alto Networks logo

Palo Alto Networks

LeaderSecurity

Network Security

Santa Clara cybersecurity platform (NASDAQ: PANW) $8.0B FY2024 revenue (+16%); platformization 3,600+ customers, Cortex XSIAM AI SOC, $4.2B NGSSAR +42%, competing with CrowdStrike and Microsoft Defender.

AI VisibilityBeta
Overall Score
A84
Category Rank
#1 of 1
AI Consensus
66%
Trend
down
Per Platform
ChatGPT
88
Perplexity
77
Gemini
92

About

Palo Alto Networks, Inc. is a Santa Clara, California-based cybersecurity platform company — publicly traded on the NASDAQ (NASDAQ: PANW) as an S&P 500 Information Technology component — providing network security, cloud security, and AI-driven security operations through three integrated security platforms: Strata (network security — next-generation firewalls, SD-WAN, Zero Trust Network Access), Prisma Cloud (cloud security posture management, cloud workload protection, CSPM/CWPP), and Cortex (AI-driven security operations — XSIAM extended security intelligence and automation management, XDR endpoint detection and response, XSOAR security orchestration) through approximately 15,000 employees worldwide. In fiscal year 2024 (ending July 2024), Palo Alto Networks reported revenues of $8.0 billion (+16% year-over-year), with next-generation security Annual Recurring Revenue (ARR — Prisma Cloud and Cortex subscriptions) growing 42% to $4.2 billion as large enterprise and government customers consolidated security toolsets onto Palo Alto Networks' platform versus maintaining dozens of point solution security vendors. CEO Nikesh Arora (joined 2018 from SoftBank as Chairman and CEO) has executed the "platformization" strategy — convincing large enterprise security buyers to replace 10-15 individual security vendors (email security, endpoint protection, cloud workload protection, network detection) with a consolidated Palo Alto Networks platform contract that provides 80% of point-solution capabilities at 50% of the total cost — using the first-year transition economics to accelerate platform adoption through deferred commitment offers (paying a lower platform price in year 1 in exchange for multi-year platform commitment in years 2-4).

Full profile

AI Visibility Head-to-Head

25
Overall Score
84
#1
Category Rank
#1
55
AI Consensus
66
up
Trend
down
31
ChatGPT
88
33
Perplexity
77
35
Gemini
92
22
Claude
87
18
Grok
89

Key Details

Category
Multifunctional Antibodies (T Cell Engagers)
Network Security
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Third Arc Bio
Multifunctional Antibodies (T Cell Engagers)
Only Palo Alto Networks
Network Security

Integrations

Only Palo Alto Networks
Palo Alto Networks is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.